title: Cochrane corner: bone morphogenetic protein (BMP) for fracture healing in adults.
abstract: BACKGROUND
  Delay in fracture healing is a complex clinical and economic issue for patients and health services.
  
  
  OBJECTIVE
  To assess the incremental effectiveness and costs of bone morphogenetic protein on fracture healing in fractures and nonunions compared with standards of care.
  
  
  METHODS
  We searched The Cochrane Library (2008, Issue 4), MEDLINE, and other major health and health economics databases (to October 2008).
  
  
  METHODS
  Randomized controlled trials (RCTs) and full or partial economic evaluations of bone morphogenetic protein for fracture healing in skeletally mature adults.
  
  
  METHODS
  All clinical and economic data were extracted by one author and checked by another.
authors.affiliation: University of Oxford and Royal Free Hospital, London, UK.
authors.forename: G E
authors.initials: GE
authors.lastname: Glass
authors.forename: A
authors.initials: A
authors.lastname: Jain
mesh_terms: D000328:Adult; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D017102:Fracture Healing / Q000187:drug effects*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
chemical_list: D019485:Bone Morphogenetic Proteins